FDA.reportPublic FDA data

Application 206961

Type
ANDA
Sponsor
NEXUS PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ISOPROTERENOL HYDROCHLORIDEISOPROTERENOL HYDROCHLORIDEINJECTABLE;INJECTION0.2MG/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
14789-011Isoproterenol HydrochlorideIsoproterenol HydrochlorideNexus Pharmaceuticals IncANDACurrent
14789-011Isoproterenol HydrochlorideIsoproterenol HydrochlorideNexus Pharmaceuticals IncANDACurrent
14789-011Isoproterenol HydrochlorideIsoproterenol HydrochlorideNexus Pharmaceuticals IncANDACurrent
14789-011Isoproterenol HydrochlorideIsoproterenol HydrochlorideNexus Pharmaceuticals IncANDACurrent
14789-011Isoproterenol HydrochlorideIsoproterenol HydrochlorideNexus Pharmaceuticals IncANDACurrent
14789-011Isoproterenol HydrochlorideIsoproterenol HydrochlorideNexus Pharmaceuticals IncANDACurrent
14789-015Isoproterenol HydrochlorideIsoproterenol HydrochlorideNexus Pharmaceuticals IncANDACurrent
14789-015Isoproterenol HydrochlorideIsoproterenol HydrochlorideNexus Pharmaceuticals IncANDACurrent
14789-015Isoproterenol HydrochlorideIsoproterenol HydrochlorideNexus Pharmaceuticals IncANDACurrent
14789-015Isoproterenol HydrochlorideIsoproterenol HydrochlorideNexus Pharmaceuticals IncANDACurrent
14789-015Isoproterenol HydrochlorideIsoproterenol HydrochlorideNexus Pharmaceuticals IncANDACurrent